Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Is This Substandard Care in Older Women with BC?
Ann Surg Oncol; ePub 2017 Jul 26; Shumway, et al
Many radiation oncologists and surgeons believe that omitting radiotherapy in older women with breast cancer is substandard care, according to a survey completed by 825 respondents. Furthermore, they tend to overestimate its benefits.
They survey was sent to more than 1,500 clinicians, generating a 55% response rate. Investigators looked at answers involving clinical scenarios, knowledge of pertinent risk information, and views on radiotherapy omission. Among the results:
- Omitting radiotherapy in patients aged ≥70 years with stage I, ER+ breast cancer treated with lumpectomy and endocrine therapy was thought to be unreasonable by 40% of surgeons and 20% of radiation oncologists.
- 3 in every 10 surgeons and 1 in every 10 radiation oncologists incorrectly linked radiotherapy in older women with improved survival.
- 32% of surgeons and 19% of radiation oncologists overestimated the risk of locoregional recurrence in older women when radiotherapy was omitted.
Shumway D, Griffith K, Sabel M, et al. Surgeon and radiation oncologist views on omission of adjuvant radiotherapy for older women with early-stage breast cancer. [Published online ahead of print July 26, 2017]. Ann Surg Oncol. doi:10.1245/s10434-017-6013-1.